Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-268-9 | CAS number: 105-08-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 22 April 2002 to 9 May 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study (OECD)
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 1,4-cyclohexanedimethanol (CHDM)
- IUPAC Name:
- 1,4-cyclohexanedimethanol (CHDM)
- Reference substance name:
- Cyclohex-1,4-ylenedimethanol
- EC Number:
- 203-268-9
- EC Name:
- Cyclohex-1,4-ylenedimethanol
- Cas Number:
- 105-08-8
- Molecular formula:
- C8H16O2
- IUPAC Name:
- cyclohexane-1,4-diyldimethanol
- Reference substance name:
- [4-(hydroxymethyl)cyclohexyl]methanol
- IUPAC Name:
- [4-(hydroxymethyl)cyclohexyl]methanol
- Details on test material:
- - Name of test material (as cited in study report): 1,4-cyclohexanedimethanol
- Substance type: pure active substance
- Physical state: White waxy solid
- Analytical purity: Min 99%
- Impurities (identity and concentrations): not available
- Composition of test material, percentage of components: 99%
- Isomers composition: not applicable
- Purity test date: not available
- Lot/batch No.: 0090
- Expiration date of the lot/batch: 31 March 2003
- Radiochemical purity (if radiolabelling): not applicable
- Specific activity (if radiolabelling): not applicable
- Locations of the label (if radiolabelling): not applicable
- Expiration date of radiochemical substance (if radiolabelling): not applicable
- Stability under test conditions: not determined
- Storage condition of test material: room temperature
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan U.K. Ltd., Bicester, Oxon, England
- Age at study initiation: approximately five to seven weeks of age
- Weight at study initiation: 90 - 107g
- Fasting period before study: overnight prior to and approximately 4 hours after dosing.
- Housing: housed in groups of three rats of the same sex in metal cages with wire mesh floors in Building F21 Room 28.
- Diet (e.g. ad libitum): Special Diet Services RM1(E) SQC expanded pellet
- Water (e.g. ad libitum): Drinking water ad libitum
- Acclimation period: five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 40-70
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12 hours of artificial light (06:00-18:00 GMT)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200mg/ml in water
- Amount of vehicle (if gavage): 10ml/kg bw
- Justification for choice of vehicle:
- Lot/batch no. (if required):
- Purity:
MAXIMUM DOSE VOLUME APPLIED: 2000mg/kg bodyweight (a single dose of the test substance) - Doses:
- 2000mg/kg
- No. of animals per sex per dose:
- A group of three fasted female(U1, U2, U3) and male(U4, U5, U6) rats at each single dose.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: All animals were observed for 14 days after dosing.
- Frequency of observations and weighing: Mortality-at least twice daily Clinical sign- Animals were observed soon after dosing and at frequent intervals for the remainder of Day 1. On subsequent days, animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15-morning only) Bodyweight-The bodyweight of each rat was recorded on Days 1 (prior to dosing), 8 and 5. Individual weekly bodyweight changes and group mean bodyweights were calculated.
- Necropsy of survivors performed: All animals killed on Day 15 by carbon dioxide asphyxiation. All animals were subjected to a microscopic examination which consisted of opening the cranial, thoracic and abdominal cavities. The macroscopic appearance of all examined organs was recorded.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- There were no deaths during the study.
- Clinical signs:
- other: Clinical signs of reaction to treatment were first noted within 30 minutes of dosing and comprised of piloerection, lethargy, abnormal gait and hunched posture seen in all rats, with partially closed eyelids, irregular respiration and pallor to the skin o
- Other findings:
- - Other observations:
Macroscopic pathology-No abnormalities were revealed at the macroscopic examination at study termination on Day 15.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute lethal oral dose (LD50) to rats of CHDM (1,4-cyclohexanedimethanol) was demonstrated to be greater than 2000 mg/kg bodyweight. It means there is low potential toxic effect.
- Executive summary:
This study was performed to assess the acute oral toxicity oral toxicity CHDM(1,4 -cyclohexanedimethanol) to the rat. A group of three fasted female rats received a single oral gavage dose of the test substance, formulated in water for irrigation, at a dose level of 2000mg/kg bodyweight. As results at this dosage indicated the acute lethal oral dose of the rest material to be greater than 2000mg/kg bodyweight, in compliance with the study guidelines, a group of three fasted males was similarly dosed at 2000mg/kg to confirm results at this dosage and complete the study. The acute lethal oral dose (LD50) to rats of CHDM (1,4 -cyclohexanedimethanol) was demonstrated to be greater than 2000mg/kg bodyweight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.